AI Analysis AI Analysis of PCRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PCRX to Watchlist?
Some Reasons Why To Add PCRX:
  • Excellent financial health (Piotroski 8/9)
  • High gross margin of 79.3%
  • Lower volatility than the market (beta 0.29)
PDF

Pacira Pharmaceuticals stock price ended at $22.99 on Friday, after losing 1.58%
(Updated on Jun 12, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 08, 2026 Gain 0.57%

The Pacira Pharmaceuticals stock price fell by -1.58% on the last day (Friday, 12th Jun 2026) from $23.36 to $22.99. During the last trading day the stock fluctuated 3.38% from a day low at $22.94 to a day high of $23.72. The price has risen in 6 of the last 10 days but is still down by -0.99% for this period. Volume has increased on the last day by 24 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 366 thousand shares were bought and sold for approximately $8.42 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Pacira Pharmaceuticals stock with a 90% probability to be traded between $22.44 and $25.83 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

PCRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 3.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pacira Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $23.04 and $23.54. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, June 02, 2026 and based on theory for this formation the price should go up by 13.36% to $26.06 within 9 trading days (Monday, June 15, 2026) since signal was issued.

Support, Risk & Stop-loss for Pacira Pharmaceuticals stock

Pacira Pharmaceuticals finds support from accumulated volume at $22.69 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.775 (3.38%) between high and low. For the last week, the stock has had daily average volatility of 3.01%.

Our recommended stop-loss: $22.01 (-4.28%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (PCRX) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Pacira Pharmaceuticals to open at $23.22, and during the day (based on 14 day Average True Range), to move between $22.55 and $23.43, which gives a possible trading interval of +/-$0.88 (+/-3.89%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $22.69 (1.30%) than the resistance at $23.35 (1.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pacira Pharmaceuticals stock A Buy?

Pacira Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.115 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $23.22 ( 0.98%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PCRX Performance

Trading levels for PCRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 23.99 4.35%
R2 23.69 3.06%
R1 23.51 2.27%
Price 22.99
S1 22.92 -0.309%
S2 22.74 -1.10%
S3 22.44 -2.39%

Accumulated Volume Support & Resistance Levels

Level Price
R3 25.49 10.87%
R2 24.44 6.31%
R1 23.35 1.57%
Price 22.99
S1 22.69 -1.30%
S2 22.11 -3.83%
S3 22.02 -4.22%

FAQ

What is the symbol for Pacira Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Pacira Pharmaceuticals is PCRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Pacira Pharmaceuticals Stock?
Pacira Pharmaceuticals holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Pacira Pharmaceuticals Stock?
Pacira Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Pacira Pharmaceuticals Stock.

What's the current price of Pacira Pharmaceuticals Stock?
As of the end of day on the Jun 12, 2026, the price of an Pacira Pharmaceuticals (PCRX) share was $22.99.

What is the 52-week high and low for Pacira Pharmaceuticals Stock?
The 52-week high for Pacira Pharmaceuticals Stock is $27.64 and the 52-week low is $18.80.

What is the market capitalization of Pacira Pharmaceuticals Stock?
As of the Jun 12, 2026, the market capitalization of Pacira Pharmaceuticals is 904.312M.

When is the next earnings date for Pacira Pharmaceuticals?
The upcoming earnings date for Pacira Pharmaceuticals is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT PACIRA PHARMACEUTICALS
Pacira Pharmaceuticals
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted ner...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE